Compound Summary
Compound Name: | SUCCINIMIDE |
Compound CID: | 11439 |
Synonyms: | SUCCINIMIDE 123-56-8 pyrrolidine-2,5-dione 2,5-Pyrrolidinedione Butanimide More... |
Iupac Name: | pyrrolidine-2,5-dione |
InChI: | InChI=1S/C4H5NO2/c6-3-1-2-4(7)5-3/h1-2H2,(H,5,6,7) |
InChIKey: | KZNICNPSHKQLFF-UHFFFAOYSA-N |
Canonical Smiles: | C1CC(=O)NC1=O |
Isomeric Smiles: | C1CC(=O)NC1=O |
Molecular Weight: | 99.09 |
Molecular Formula: | C4H5NO2 |
Molecular Weight: | 99.09 |
Molecular Formula: | C4H5NO2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 7 |
Complexity: | 105 |
SUCCINIMIDE | SUCCINIMIDE |
---|---|
SUCCINIMIDE |
123-56-8 |
pyrrolidine-2,5-dione |
2,5-Pyrrolidinedione |
Butanimide |
Succinic acid imide |
2,5-Dioxopyrrolidine |
2,5-Diketopyrrolidine |
Succinic imide |
Succinimide-sauba |
3,4-Dihydropyrrole-2,5-dione |
Dihydro-3-pyrroline-2,5-dione |
3,4-Dihydropyrrolidine |
NSC 11204 |
SUCCIMIDE |
UNII-10X90O3503 |
MFCD00005495 |
CHEBI:9307 |
2,5-Pyrrolidinedione, homopolymer |
azolidine-2,5-dione |
Mercuric imidosuccinate |
Mercury, disuccinimido- |
WLN: T5VMVTJ |
2, mercury(2+) salt |
10X90O3503 |
Succinimide, mercury(2+) salt |
25950-42-9 |
584-43-0 |
EINECS 204-635-6 |
BRN 0108440 |
succinimid |
cis-succinimide |
AI3-08539 |
Succinimide (SI) |
2,5dioxopyrrolidine |
Lubrizol 6406 |
pyrroldine-2,5-dione |
succinimide(butanimide) |
ACMC-1BRIF |
Succinimide pharbiol (TN) |
EC 204-635-6 |
DSSTox_CID_30181 |
DSSTox_GSID_51629 |
5-21-09-00438 (Beilstein Handbook Reference) |
Maleimide-Related Compound 13 |
BDBM7814 |
CHEMBL275661 |
DTXSID8051629 |
EBD46423 |
NSC11204 |
NSC13114 |
NSC38417 |
NSC41221 |
NSC49152 |
ZINC5133396 |
Tox21_303851 |
BBL011626 |
NSC-11204 |
NSC-13114 |
NSC-38417 |
NSC-41221 |
NSC-49152 |
SBB040866 |
STL163344 |
AKOS000118776 |
DB13376 |
MCULE-8278049979 |
NCGC00357119-01 |
BP-21153 |
CAS-123-56-8 |
BB 0322715 |
FT-0658724 |
ST50214456 |
Succinimide, Vetec(TM) reagent grade, 98% |
C07273 |
D08532 |
21180-EP2269983A1 |
21180-EP2269984A1 |
21180-EP2277880A1 |
21180-EP2284157A1 |
21180-EP2292593A2 |
21180-EP2292610A1 |
21180-EP2301918A1 |
21180-EP2305648A1 |
21180-EP2305651A1 |
21180-EP2305658A1 |
21180-EP2305671A1 |
21180-EP2305769A2 |
21180-EP2308854A1 |
21180-EP2311804A2 |
21180-EP2311825A1 |
21180-EP2314295A1 |
21180-EP2314587A1 |
21180-EP2371797A1 |
21180-EP2371798A1 |
21180-EP2371800A1 |
21180-EP2371804A1 |
150414-EP2281822A1 |
150414-EP2284157A1 |
150414-EP2289892A1 |
Q419430 |
Z57127349 |
F1908-0169 |
1BBF5533-77F1-4B20-96F3-0BB022C36CD3 |
Succinic imide; Succinic acid imide; Butanimide; 2,5-Dioxopyrrolidine; 2,5-Diketopyrrolidine; 2,5-Pyrrolidinedione |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 10 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 5 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 10 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 50 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 50 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 5 | mM | Unclear | N2 | 33683565 | ||||||||
Caenorhabditis elegans | 2 | mg/mL | -4 | 1 | NS | N2 | 33683565 | Inactive | |||||
Caenorhabditis elegans | 2 | mg/mL | 16.7 | 16 | -4 | 23.3 | 23.5 | 1 | Unclear | N2 | 15653505 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -4 | 1 | 2 | 8 |